Cancer: Scientists find 'microbial link' between one popular diet and the deadly disease
EVIDENCE linking diet to cancer is abundant, but the mechanisms behind this relationship remain largely unknown. A new study has discovered a microbial link between one diet and colon cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - June 28, 2022 Category: Consumer Health News Source Type: news
Ghana: Study - Konkonte Fights Colon Cancer, Lowers Blood Sugar
[Ghanaian Times] Before we delve into the article, let me state that: Prof. Nyarkotey has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical associations to justify his write-ups. My articles are for educational pur-poses and do not serve as medical advice for diagnosis or treatment. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 24, 2022 Category: African Health Source Type: news
Mayo Clinic Q and A: What is the benefit of visiting a genetic counselor?
DEAR MAYO CLINIC: My grandmother and mother, as well as an aunt and a cousin, have had breast cancer. Another cousin was diagnosed with colon cancer recently. It has been suggested that I undergo genetic counseling to determine my cancer risk. As a young man, is genetic testing necessary for me? What benefit would I gain from visiting a genetic counselor? ANSWER: Although it can be daunting to have a loved one diagnosed with cancer, having a… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 12, 2022 Category: Databases & Libraries Source Type: news
Gene Test Lets Some Colon Cancer Patients Safely Skip Chemo
Title: Gene Test Lets Some Colon Cancer Patients Safely Skip ChemoCategory: Health NewsCreated: 6/7/2022 12:00:00 AMLast Editorial Review: 6/8/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 8, 2022 Category: Cancer & Oncology Source Type: news
Gene Test Lets Some Colon Cancer Patients Safely Skip Chemo
New studies show a blood test could save some colon cancer patients from getting unnecessary chemotherapy following surgery, while making sure that those who would benefit from the treatment get it. (Source: WebMD Health)
Source: WebMD Health - June 7, 2022 Category: Consumer Health News Source Type: news
Gene Test Lets Some Colon Cancer Patients Safely Skip Chemo
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 7, 2022 Category: Cancer & Oncology Tags: Nursing, Oncology, Research, News, Source Type: news
Gene Test Lets Some Colon Cancer Patients Safely Skip Chemo
TUESDAY, June 7, 2022 -- A blood test could save some colon cancer patients from getting unnecessary chemotherapy following surgery, while making sure that those who would benefit from the treatment get it, researchers report.
The circulating tumor... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 7, 2022 Category: General Medicine Source Type: news
Liquid Biopsy May Save Colon Cancer Patients From Chemo
(MedPage Today) -- CHICAGO – Early colon cancer patients who have circulating tumor DNA detected in blood may need more aggressive treatment, but people who have a negative liquid biopsy appear to be safe in avoiding chemotherapy –... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 6, 2022 Category: Gastroenterology Source Type: news
ASCO: ctDNA Analysis Guides Treatment of Stage II Colon Cancer
ctDNA - guided approach to determining the need for adjuvant therapy noninferior to standard management for recurrence - free survival (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 6, 2022 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pathology, Pharmacy, Conference News, Source Type: news
ASCO: ctDNA Analysis Guides Treatment of Stage II Colon Cancer
MONDAY, June 6, 2022 -- A circulating tumor DNA (ctDNA)-guided approach to treatment of stage II colon cancer reduces adjuvant chemotherapy use without affecting recurrence-free survival, according to a study published online June 4 in the New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 6, 2022 Category: Pharmaceuticals Source Type: news
Small Study on Rectal Cancer Results in Remission in Every Patient
The study was small, and experts say it needs to be replicated. But for 18 people with rectal cancer, the outcome led to “happy tears.” (Source: NYT Health)
Source: NYT Health - June 5, 2022 Category: Consumer Health News Authors: Gina Kolata Tags: Colon and Colorectal Cancer Drugs (Pharmaceuticals) Clinical Trials Research Immunotherapy American Society of Clinical Oncology New England Journal of Medicine GlaxoSmithKline PLC Source Type: news
A Cancer Trial ’s Unexpected Result: Remission in Every Patient
The study was small, and experts say it needs to be replicated. But for 18 people with colorectal cancer, the outcome led to “happy tears.” (Source: NYT Health)
Source: NYT Health - June 5, 2022 Category: Consumer Health News Authors: Gina Kolata Tags: Colon and Colorectal Cancer Drugs (Pharmaceuticals) Clinical Trials Research Immunotherapy American Society of Clinical Oncology New England Journal of Medicine GlaxoSmithKline PLC Source Type: news
ctDNA Identifies Colon Cancer Patients Who Can Skip Chemo ctDNA Identifies Colon Cancer Patients Who Can Skip Chemo
A liquid biopsy to detect circulating tumor DNA after surgery for stage 2 colon cancer reduces the use of chemotherapy without sacrificing recurrence-free survival.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 4, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Pandemic Caused Millions of U.S. Women to Skip Cancer Screenings
FRIDAY, June 3, 2022 -- Millions of U.S. women missed breast, cervical and colon cancer screenings due to the COVID-19 pandemic, according to a new study.
It found that compared to 2018, the number of women in 2020 who said they had breast cancer... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 3, 2022 Category: General Medicine Source Type: news
Janssen Presents Study Results Showing Clinical Efficacy for TREMFYA ® (guselkumab) and Long-Term Safety Profile for STELARA® (ustekinumab) for Patients Living with Inflammatory Bowel Disease at Digestive Disease Week® 2022
SPRING HOUSE, PENNSYLVANIA, May 24, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 2 GALAXI 1 clinical trial of TREMFYA® (guselkumab) in adult patients with moderately to severely active Crohn’s disease (CD), and from three separate long-term pooled analyses of adult patients with ulcerative colitis (UC) and CD treated with STELARA® (ustekinumab).1,2,3,4 These data are being presented as oral and poster presentations and are among 29 Janssen abstracts presented during the Digestive Disease Week® (DDW) meeting taking place in person and virtually in San Di...
Source: Johnson and Johnson - May 24, 2022 Category: Pharmaceuticals Source Type: news
